BeStock  
Stocks › Biotechnology › LGND

Ligand Pharmaceuticals LGND

US equityMarket cap rank #1897Biotechnology
$286.85 −$0.09 (-0.03%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $286.85 0.00%
Open$285.21
Prev close$286.94
Day range$282.36 – $291.36
Volume259.8K
Market cap$5.74B
P/E (TTM)115.2
Dividend yield–

LGND Stock News

Headlines matching Ligand Pharmaceuticals or the LGND ticker, most recent first.

  • Barclays Initiates Ligand Pharmaceuticals(LGND.US) With Buy Rating, Announces Target Price $345Market news · 25 Sep 2026 · Direct mention
  • Citi Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $397Market news · 24 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $358Market news · 24 Sep 2026 · Direct mention
  • Craig-Hallum Maintains Ligand Pharmaceuticals(LGND.US) With Buy RatingMarket news · 24 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Ligand Pharmaceuticals(LGND.US), With a Forecast Between $388 to $397Market news · 23 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Ligand Pharmaceuticals(LGND.US), With a Forecast Between $326 to $370Market news · 8 Aug 2026 · Direct mention
  • RBC Capital Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $345 PositiveMarket news · 7 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $358 PositiveMarket news · 7 Aug 2026 · Direct mention
  • Oppenheimer Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $326 PositiveMarket news · 3 Aug 2026 · Direct mention
  • Stifel Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $332Market news · 14 Aug 2026 · Direct mention
  • Citi Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $390 PositiveMarket news · 12 Aug 2026 · Direct mention
  • RBC Capital Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $345Market news · 10 Aug 2026 · Direct mention
  • BofA Securities Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $388 PositiveMarket news · 9 Jul 2026 · Direct mention
  • Stifel Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $332 PositiveMarket news · 8 Jul 2026 · Direct mention
  • BofA Securities Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $388Market news · 22 Jul 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on LGND.

Sign in to join the discussion.

Scroll to Top